Alec Amar 10b5-1 sales show 82,500 RSUs involved (DGXX)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Alec Amar reported sales of common stock under a 10b5-1 plan.
The filing lists three 10b5-1 sale transactions: 27,500 shares on 12/04/2025 for $100,523.50, 27,500 shares on 01/02/2026 for $74,690.00, and 27,500 shares on 02/02/2026 for $69,616.25.
The cover data also shows 82,500 restricted stock units dated 01/11/2024 and lists Morgan Stanley Smith Barney LLC as the broker.
Positive
- None.
Negative
- None.
FAQ
What transactions does the DGXX Form 144 show for Alec Amar?
The Form 144 shows three 10b5-1 sales of common stock by Alec Amar. Each sale was for 27,500 shares on 12/04/2025, 01/02/2026, and 02/02/2026 with proceeds listed for each transaction.
How much did Alec Amar receive from each 10b5-1 sale in the filing?
The filing lists proceeds of $100,523.50 for the 12/04/2025 sale, $74,690.00 for the 01/02/2026 sale, and $69,616.25 for the 02/02/2026 sale, as stated in the Form 144.
What securities are identified as to be sold in the DGXX filing?
The filing identifies restricted stock units dated 01/11/2024 with a listed amount of 82,500 units. The entry labels the securities as common stock/RSUs and names the issuer relationship.
Which broker is named on the Form 144 for DGXX?
The Form 144 lists Morgan Stanley Smith Barney LLC, Executive Financial Services as the broker, with an address of 1 New York Plaza, 8th Floor, New York, NY 10004, as shown in the filing.
Are the DGXX sales described as part of a 10b5-1 plan?
Yes. Each disclosed sale is labeled as a 10b5-1 Sale for Alec Amar in the document, indicating the transactions were executed under a prearranged trading plan as stated in the filing.